Different modulation of inhibitory and stimulatory pathways mediated by adenosine after chronic in vivo agonist exposure

Brain Research

Volumn 1031, Issue 2, 2005, Pages 211-221

  Ruiz, María Ángeles ^a   Albasanz, José Luis ^a   León, David ^a   Ros, Manuel ^a   Andrés, Antonio ^a   Martín, Mairena ^a  

^a Organ Y Bioquim   (Spain)

Author keywords

Adenosine receptors; Adenylyl cyclase; Down regulation; G proteins; Rat

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHENYLISOPROPYLADENOSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANE;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; BINDING SITES; BRAIN; CELL MEMBRANE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MALE; NEURAL INHIBITION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANES;

EID: 11844301615     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.10.040     Document Type: Article

References (57)

1. M.P. Abbracchio, and F. Cattabeni Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases Ann. N. Y. Acad. Sci. 890 1999 79 92
2. J.L. Albasanz, D. Leon, M.A. Ruiz, M. Fernadez, and M. Martin Adenosine A1 receptor agonist treatment up-regulates rat brain metabotropic glutamate receptors Biochim. Biophys. Acta 1593 2002 69 75
3. M.B. Anand-Srivastava, M. Cantin, M. Ballak, and S. Picard Desensitization of the stimulatory A2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta Mol. Cell. Endocrinol. 62 1989 273 279
4. R.F. Bruns, G.H. Lu, and T.A. Pugsley Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes Mol. Pharmacol. 29 1986 331 346
5. M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S.R. Goldberg, K. Neve, K. Fuxe, L.F. Agnati, A.S. Woods, S. Ferre, C. Lluis, M. Bouvier, and R. Franco Adenosine A2A-dopamine D2 receptor-receptor heteromerization J. Biol. Chem. 278 2003 46741 46749
6. Y. Chern, H.L. Lai, J.C. Fong, and Y. Liang Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells Mol. Pharmacol. 44 1993 950 958
7. A. Conti, G. Lozza, and A. Monopoli Prolonged exposure to 5-(N-ethylcarboxamido)adenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries Pharmacol. Res. 35 1997 123 128
8. S. Dasgupta, S. Ferre, B. Kull, P.B. Hedlund, U.B. Finnman, S. Ahlberg, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine AZA receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells Eur. J. Pharmacol. 316 1996 325 331
9. J.M. Davis, Z. Zhao, H.S. Stock, K.A. Mehl, J. Buggy, and G.A. Hand Central nervous system effects of caffeine and adenosine on fatigue Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 2003 R399 R404
10. A.K. Dixon, A.K. Gubitz, D.J. Sirinathsinghji, P.J. Richardson, and T.C. Freeman Tissue distribution of adenosine receptor mRNAs in the rat Br. J. Pharmacol. 118 1996 1461 1468
11. A.K. Dixon, L. Widdowson, and P.J. Richardson Desensitization of the adenosine A1 receptor by the A2A receptor in the rat striatum J. Neurochem. 69 1997 315 321
12. W.T. Donahoo, D.R. Jensen, T.J. Yost, and R.H. Eckel Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion J. Clin. Endocrinol. Metab. 82 1997 4139 4143
13. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annu. Rev. Neurosci. 24 2001 31 55
14. M.J. Durcan, and P.F. Morgan Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice Eur. J. Pharmacol. 168 1989 285 290
15. I. Feoktistov, and I. Biaggioni Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes Mol. Pharmacol. 43 1993 909 914
16. I. Feoktistov, and I. Biaggioni Adenosine A2B receptors Pharmacol. Rev. 49 1997 381 402
17. S. Ferre, P. Popoli, L. Gimenez-Llort, U.B. Finnman, E. Martinez, A. Scotti de Carolis, and K. Fuxe Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors NeuroReport 6 1994 73 76
18. S. Ferre, M. Torvinen, K. Antoniou, E. Irenius, O. Civelli, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells J. Biol. Chem. 273 1998 4718 4724
19. R. Franco, S. Ferre, L. Agnati, M. Torvinen, S. Gines, J. Hillion, V. Casado, P. Lledo, M. Zoli, C. Lluis, and K. Fuxe Neuropsychopharmacology 23 2000 S50 S59
20. B.B. Fredholm, A.P. Ijzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
21. S. Gines, J. Hillion, M. Torvinen, S. Le Crom, V. Casado, E.I. Canela, S. Rondin, J.Y. Lew, S. Watson, M. Zoli, L.F. Agnati, P. Vernier, C. Lluis, S. Ferre, K. Fuxe, R. Franco, Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes 97 (2000) 8606-8611.
22. G. Gonzalez-Calero, M. Martin, A. Cubero, and A. Andres Bovine brain coated vesicles contain adenosine A1 receptors. Presence of adenylate cyclase coupled to the receptor J. Neurochem. 55 1990 106 113
23. A. Green Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist J. Biol. Chem. 262 1987 15702 15707
24. J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens 5-(N-ethylcarboxamido) adenosine desensitizes the A2b-adenosine receptor in lung circulation Am. J. Physiol. 276 1999 H1877 H1883
25. C.C. Helfman, H. Zhong, R.A. Barraco, and G.F. Anderson The effects of 5′-N-ethylcarboxamidoadenosine on evoked release of [3H]serotonin in the rat nucleus tractus solitarius Neurosci. Lett. 213 1996 61 65
26. I. Hide, W.L. Padgett, K.A. Jacobson, and J.W. Daly A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase Mol. Pharmacol. 41 1992 352 359
27. B.B. Hoffman, H. Chang, E. Dall'Aglio, and G.M. Reaven Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocites J. Clin. Invest. 78 1986 185 190
28. R. Karlsten, T. Gordh Jr., P. Hartvig, and C. Post Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat Anesth. Analg. 71 1990 60 64
29. K. Kessey, B.L. Trommer, L.S. Overstreet, T. Ji, and D.J. Mogul A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus Brain Res. 756 1997 184 190
30. M. Klinger, M. Freissmuth, and C. Nanoff Adenosine receptors: G protein-mediated signalling and the role of accessory proteins Cell. Signal. 14 2002 99 108
31. H.T. Lee, C.I. Thompson, A. Hernandez, J.L. Lewy, and F.L. Belloni Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo Am. J. Physiol. 265 1993 H1916 H1927
32. H.T. Lee, A. Cuomo-Scholer, F.L. Belloni, and C.I. Thompson Regulation of renal A(1) adenosine receptors in vivo Exp. Nephrol. 10 2002 43 50
33. J.P. Longabaugh, J. Didsbury, A. Spiegel, and G.L. Stiles Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs Mol. Pharmacol. 36 1989 681 688
34. L.V. Lopes, R.A. Cunha, and J.A. Ribeiro Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats J. Neurophysiol. 82 1999 3196 3203
35. A. Matharu, S.J. Mundell, J.L. Benovic, and E. Kelly Rapid agonist-induced desensitization and internalization of the A2B adenosine receptor is mediated by a serine residue close to the COOH terminus J. Biol. Chem. 276 2001 30199 30207
36. J.L. Moreau, and G. Huber Central adenosine A(2A) receptors: an overview Brain Res. Brain Res. Rev. 31 1999 65 82
37. D.M. Morse, J.L. Smullen, and C.W. Davis Differential effects of UTP, ATP and adenosine on ciliary activity of human nasal epithelial cells Am. J. Physiol., Cell. Physiol. 280 2001 C1485 C1497
38. S.J. Mundell, and E. Kelly Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells Biochem. Pharmacol. 55 1998 595 603
39. T. Ogata, Y. Nakamura, and P. Schubert Potentiated cAMP rise in metabotropically stimulated rat cultured astrocytes by a Ca2+-related A1/A2 adenosine receptor cooperation Eur. J. Neurosci. 8 1996 1124 1131
40. M. Okada, K. Mizuno, and S. Kaneko Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum Neurosci. Lett. 212 1996 53 56
41. T.M. Palmer, T.W. Gettys, K.A. Jacobson, and G.L. Stiles Desensitization of the canine A2a adenosine receptor: delineation of multiple processes Mol. Pharmacol. 45 1994 1082 1094
42. M.C. Peakman, and S.J. Hill Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes Br. J. Pharmacol. 111 1994 191 198
43. D.M. Peters, E.K. Gies, C.R. Gelb, and R.A. Peterfreund Agonist-induced desensitization of A2B adenosine receptors Biochem. Pharmacol. 55 1998 873 882
44. J.W. Phillis, R.A. Barraco, R.E. DeLong, and D.O. Washington Behavioral characteristics of centrally administered adenosine analogs Pharmacol. Biochem. Behav. 24 1986 263 270
45. N.M. Porter, M. Radulovacki, and R.D. Green Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogs J. Pharmacol. Exp. Ther. 244 1988 218 225
46. V. Ralevic, and G. Burnstock Receptors for purines and pyrimidines Pharmacol. Rev. 50 1998 413 492
47. S.M. Reppert, D.R. Weaver, J.H. Stehle, and S.A. Rivkees Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord Mol. Endocrinol. 5 1991 1037 1048
48. J.A. Ribeiro Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators Eur. J. Pharmacol. 375 1999 101 113
49. A.M. Rice, J.N. Fain, and S.A. Rivkees A1 adenosine receptor activation increases adipocyte leptin secretion Endocrinology 141 2000 1442 1445
50. D.L. Rosin, A. Robeva, R.L. Woodard, P.G. Guyenet, and J. Linden Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system J. Comp. Neurol. 401 1998 163 186
51. A. Ruiz, J.M. Sanz, G. Gonzalez-Calero, M. Fernandez, A. Andres, A. Cubero, and M. Ros Desensitization and internalization of adenosine A1 receptors in rat brain by in vivo treatment with R-PIA: involvement of coated vesicles Biochim. Biophys. Acta 1310 1996 168 174
52. A. Tedde, M.E. Balis, S. Ikehara, R. Pahwa, R.A. Good, and P.P. Trota Animal model for immune dysfunction associated with adenosine deaminase deficiency Proc. Natl. Acad. Sci. U. S. A. 77 1980 4899 4903
53. S.J. Vannucci, C.M. Klim, L.F. Martin, S. Ranta, K.F. LaNoue, and J.J. Ohisalo A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats Am. J. Physiol. 257 1989 E871 E878
54. D. Vendite, J.M. Sanz, D.M. Lopez-Alanon, J. Vacas, A. Andres, and M. Ros Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells Neurochem. Res. 23 1998 211 218
55. D.K. von Lubitz Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 371 1999 85 102
56. 3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites J. Neurochem. 55 1990 1763 1771
57. R.L. Webb, M.A. Sills, J.P. Chovan, J.V. Peppard, and J.E. Francis Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration J. Pharmacol. Exp. Ther. 267 1993 287 295